Trading Signals: UTHR Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Fri. Dec. 22, 2023)( United Therapeutics Corp)
| UTHR latest price $276.0900 (1.04%) ($276.0900 - $276.0900) on Thu. Dec. 22, 2022. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 1.98% (three month average) | RSI | 46 | Latest Price | $276.0900(1.04%) | Stocks Behave Similarly | Similar Stock List | Weekly Trend | UTHR declines -0.5% a week on average for past two weeks. | Market Behavior | Broad based sell-off for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support UTHR advance at 0% a week (0% probability) XLV(44%) VYM(34%) XLP(30%) XBI(29%) XLF(28%) | Factors Impacting UTHR price | UTHR will decline at least -0.99% in a week (0% probabilities). VXX(-20%) ACES(-13%) VIXM(-12%) BND(-11%) UUP(-8%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -0.99% (StdDev 1.98%) | Hourly BBV | 1.1 () | Intraday Trend | 0% | | | |
|
5 Day Moving Average | $274.79(0.47%) | 10 Day Moving Average | $276.31(-0.08%) | 20 Day Moving Average | $275.82(0.1%) | To recent high | -1.5% | To recent low | 35.9% | Market Cap | $12.246b | | | | United Therapeutics Corp. operates as a biotechnology company, which engages in the development and commercialization of products for patients with chronic and life-threatening diseases. It markets and sells commercial therapies to treat pulmonary arterial hypertension and high-risk neuroblastoma. The firm also involves in the research and development of new indications and delivery devices for its product, and for the organ transplantation-related technologies. The company was founded by Martine A. Rothblatt on June 26, 1996 and is headquartered in Silver Spring, MD. |